--2025/Q1-- / 16.523M--
--2024/Q4-- / 14.160M--
Oct 29, 20242024/Q311.871M / 10.854M--
Jul 31, 20242024/Q28.654M / 8.867M--
Apr 25, 20242024/Q17.902M / 5.187M--
US Stock MarketDetailed Quotes
SAGE Sage Therapeutics
- 4.920
- +0.010+0.20%
Trading Nov 21 11:11 ET
300.97MMarket Cap-883P/E (TTM)
5.190High4.910Low268.28KVolume5.020Open4.910Pre Close1.34MTurnover0.56%Turnover RatioLossP/E (Static)61.17MShares28.26052wk High0.55P/B237.89MFloat Cap4.62052wk Low--Dividend TTM48.35MShs Float195.970Historical High--Div YieldTTM5.70%Amplitude4.620Historical Low5.007Avg Price1Lot Size
Sage Therapeutics Key Stats
Sage Therapeutics Q3 2024 Earnings Date
Currency：USDOct 29, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 10.85M | 11.87M | +1.02M |
| Beat Est. | +299.62% | +337.08% | +9.37% |
| EPS | -1.54 | -1.53 | +<0.01 |
| Beat Est. | +54.38% | +54.60% | +0.47% |
Analyst Rating
Nov 21, 2024
Sage Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Sage Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data